个人简历
工作经历： 2018/07-今，华中科技大学，药学院 2016/09-2018/02，昆士兰大学，AIBN 2016/04-2018/06，华中科技大学，基础医学院，博士后 教育经历 2013/09-2015/10，北卡罗来纳大学教堂山，联合培养博士 2009/09-2016/01，华中科技大学，博士 2005/09-2009/06，华中科技大学，药学院，本科
研究领域
主要从事新型药物递释系统的研究，近几年着重在新型递释系统用于肿瘤免疫治疗联合化疗、基因治疗等方面的研究。
近期论文
(1) Yannan Yang#, Yao Lu #, et al. Stepwise degradable nanocarriers enabled cascade delivery for synergistic cancer therapy. Advanced Functional Materials, (2018), 28: 1800706. (共同第一作者) （IF=13.325） (2) Yao Lu#, Yannan Yang#, et al. Glutathione-Depletion Mesoporous Organosilica Nanoparticles as a Self-Adjuvant and Co-delivery Platform for Enhanced Cancer Immunotherapy. Biomaterials. 2018,82-92. (IF= 8.806) (3) Hao Song, Meihua Yu, Yao Lu, Zhengying Gu, et al. Plasmid DNA Delivery: Nanotopography Matters, Journal of the American Chemical Society, 2017, 139(50): 18247-18254. （IF=14.357) (4) Yannan Yang#, Yao Lu#, Prasanna Lakshmi Abbaraju, et al. Multi‐shelled Dendritic Mesoporous Organosilica Hollow Spheres: Roles of Composition and Architecture in Cancer Immunotherapy, Angewandte Chemie, 2017, 129(29): 8566-8570 (共同第一作者) （IF=12.12） (5) Yao Lu, Yuhua Wang, Lei Miao, Matthew Haynes, et al. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: a combination nanomedicine approach, Cancer letters, 2016, 379(1): 32-38. （IF＝6.491） (6) Yao Lu, Lei Miao, Yuhua Wang, Zhenghong Xu, et al. Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model. Molecular Therapy. 2016. 24(2): 364-374 (IF=7.008) (7) Yao Lu#, Nan Ding#, Chang Yang, Lei Huang L, Jian Liu, Guangya Xiang. Preparation and in vitro Evaluation of a Folate-Linked Liposomal Curcumin Formulation. Journal of Liposome Research. 2012, 22, 110-119. (8) Nan Ding＃，Yao Lu#， Robert J Lee#， Chang Yang， Lei Huang， Jian Liu， Guangya Xiang，Folate receptor targeted fluorescent paramagnetic bimodal liposomes for tumor imaging, International Journal of Nanomedicine，2011,6:2513-2520 (共同第一作者) (9) Peng Ye, Wendian Zhang, Tan Yang, Yao Lu, Mao Lu, Yongkang Gai, Xiang Ma, Guangya Xiang. Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting. International Journal of Nanomedicine. 2014, 9, 2167-2178.
